antispsychotic drugs antispsychotic drugs
Stories About

antispsychotic drugs

The FDA has approved the first drug with "a digital ingestion tracking system." Abilify MyCite is an antipsychotic with an ingestible sensor that transmits data to a patch, which then sends the information to a smartphone app. Proteus Digital Health hide caption

toggle caption
Proteus Digital Health

Researchers find that dementia patients who engage in activities such as gathering photographs and talking about family see improvements in their quality of life and are less agitated. Owen Franken/Getty Images hide caption

toggle caption
Owen Franken/Getty Images

About 1 in 3 patients with dementia who live in nursing homes are being sedated with antipsychotic drugs, the GAO says. Outside nursing homes, about 1 in 7 dementia patients are getting the risky drugs. Wladimir Bulgar/iStockphoto hide caption

toggle caption
Wladimir Bulgar/iStockphoto

GAO Report Urges Fewer Antipsychotic Drugs For Dementia Patients

  • Download
  • <iframe src="https://www.npr.org/player/embed/390245017/390245018" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript